Evaluating vaccines for HIV prevention using nonhuman primates
Simian Vaccine Evaluation Unit: Core Activities - Administrative and Technical Support
['FUNDING_OTHER'] · BIOQUAL, INC. · NIH-10610287
This study is testing new AIDS vaccines and prevention methods using monkeys to see how well they can help the immune system fight HIV, with the goal of finding effective options for people.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | BIOQUAL, INC. (nih funded) |
| Locations | 1 site (ROCKVILLE, UNITED STATES) |
| Trial ID | NIH-10610287 on ClinicalTrials.gov |
What this research studies
This research focuses on the evaluation of candidate AIDS vaccines and prevention strategies using nonhuman primates (NHPs) in preclinical studies. The Simian Vaccine Evaluation Units (SVEUs) provide essential resources for researchers to conduct thorough assessments of immune responses and vaccine efficacy. By utilizing NHP models, the research aims to identify effective vaccines that can generate immune responses capable of preventing or controlling HIV infection. The program supports all stages of AIDS vaccine research, from initial evaluations to clinical testing.
Who could benefit from this research
Good fit: Ideal candidates for benefiting from this research include individuals at high risk for HIV infection who may eventually receive effective vaccines developed through these studies.
Not a fit: Patients who are already living with HIV or those who do not have access to vaccination programs may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of effective vaccines that prevent HIV infection, significantly impacting public health.
How similar studies have performed: Previous research using nonhuman primates for HIV vaccine evaluation has shown promise, indicating that this approach is both tested and has the potential for significant breakthroughs.
Where this research is happening
ROCKVILLE, UNITED STATES
- BIOQUAL, INC. — ROCKVILLE, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: LEWIS, MARK — BIOQUAL, INC.
- Study coordinator: LEWIS, MARK
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.